Published in J Immunol on November 01, 1982
A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J Virol (1988) 2.34
Viral parkinsonism. Biochim Biophys Acta (2008) 1.57
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48
Gut mucosal immunization with reovirus serotype 1/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches. J Exp Med (1987) 1.48
Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes. J Virol (1987) 1.47
Role of immune cells in protection against and control of reovirus infection in neonatal mice. J Virol (1991) 1.20
Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. Clin Exp Immunol (1987) 1.16
The reovirus nonstructural protein sigma1NS is recognized by murine cytotoxic T lymphocytes. J Virol (1996) 0.80
Experimental intestinal reovirus infection of mice: what we know, what we need to know. Immunol Res (2005) 0.79
Cell receptors for the mammalian reovirus: reovirus-specific T-cell hybridomas can become persistently infected and undergo autoimmune stimulation. J Virol (1986) 0.78
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol (1988) 4.77
Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A (1977) 3.97
Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J Virol (1977) 3.87
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Isolation and preliminary genetic and biochemical characterization of temperature-sensitive mutants of reovirus. Virology (1969) 3.66
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis (1980) 3.27
Intestinal M cells: a pathway for entry of reovirus into the host. Science (1981) 3.23
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology (1982) 2.55
Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med (1977) 2.53
Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes. Virology (1978) 2.51
Host restriction of Friend leukemia virus. Role of the viral outer coat. Proc Natl Acad Sci U S A (1973) 2.44
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J Virol (1989) 2.38
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1990) 2.37
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol (1991) 2.37
Activation and characterization of the reovirus transcriptase: genetic analysis. J Virol (1982) 2.36
Molecular basis of reovirus virulence. Role of the M2 gene. J Exp Med (1980) 2.32
A carboxy-terminal fragment of protein mu 1/mu 1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol (1992) 2.29
Identification of the gene coding for the hemagglutinin of reovirus. Virology (1978) 2.28
Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell (1981) 2.23
Intracellular synthesis of measles virus-specified polypeptides. J Virol (1978) 2.21
The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens. J Exp Med (1978) 2.20
Polymorphism of the migration of double-stranded RNA genome segments of reovirus isolates from humans, cattle, and mice. J Virol (1979) 2.15
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Characterization of a zinc blotting technique: evidence that a retroviral gag protein binds zinc. Proc Natl Acad Sci U S A (1988) 2.13
Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature (1982) 2.11
Mammalian reoviruses contain a myristoylated structural protein. J Virol (1991) 2.09
Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology (1982) 2.08
Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol (1980) 2.06
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis (1995) 2.05
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci U S A (1989) 2.05
Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut (2009) 2.01
Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol (1993) 1.99
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery (1988) 1.98
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res (1998) 1.97
Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3. Mol Cell Biol (1988) 1.96
Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology (1983) 1.95
Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature (1985) 1.95
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Ann Intern Med (1985) 1.89
The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal. Am J Med (1967) 1.88
A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments. Virology (1978) 1.87
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol (1992) 1.86
Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol (1982) 1.84
Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science (1983) 1.82
Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol (1989) 1.82
Temperature-sensitive mutants of reovirus type 3: studies on the synthesis of viral RNA. Virology (1972) 1.77
Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol (1994) 1.75
Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature (1982) 1.75
Hemagglutinin of rabies and some other bullet-shaped viruses. Proc Soc Exp Biol Med (1968) 1.74
Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host. J Clin Invest (1991) 1.73
A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3. Virology (1978) 1.72
Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J Virol (1990) 1.71
Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence. Proc Natl Acad Sci U S A (1982) 1.71
Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A (1985) 1.70
Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions. J Virol (1990) 1.69
Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses. Proc Natl Acad Sci U S A (1993) 1.64
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J Virol (1989) 1.64
The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice. Virology (1983) 1.63
Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A (1991) 1.60
Use of IFN-gamma in patients with AIDS. J Acquir Immune Defic Syndr (1990) 1.59
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med (1989) 1.59
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc Natl Acad Sci U S A (1978) 1.58
Role of the mu 1 protein in reovirus stability and capacity to cause chromium release from host cells. J Virol (1996) 1.58
Identification of a new polypeptide coded by reovirus gene S1. J Virol (1985) 1.57
A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J Virol (1990) 1.57
Why the smallpox virus stocks should not be destroyed. Science (1993) 1.56
Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J Virol (1990) 1.56
Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J Virol (1993) 1.55
The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology (1982) 1.55
Temperature-sensitive mutants of reovirus type 3 features of genetic recombination. Virology (1971) 1.53
Genetic manipulation of reovirus--a model for modification of disease. N Engl J Med (1972) 1.53
The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol (1989) 1.52
Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol (1979) 1.52
Crystallization of the reovirus type 3 Dearing core. Crystal packing is determined by the lambda 2 protein. J Mol Biol (1990) 1.51
Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science (1983) 1.50
Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology (1971) 1.50
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A (1979) 1.50
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J Virol (1993) 1.48
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48
Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol (1983) 1.46
Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol (1990) 1.44
Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci U S A (1986) 1.43
Reovirus-specific polypeptides: analysis using discontinuous gel electrophoresis. J Virol (1976) 1.42
Internal/structures containing transcriptase-related proteins in top component particles of mammalian orthoreovirus. Virology (1998) 1.42